Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in ATOS — Atossa Therapeutics, Inc.

CIK 820027 MINNEAPOLIS, MN
Back to ATOS Full portfolio

Position in ATOS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$498,391
-$843,613 QoQ
Shares Held
258,234
+1.2% QoQ
Ownership
2.59%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 31 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. ATOS ranks #175 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in ATOS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $498,391 258,234
2026-03-31 $1,342,004 255,134
2025-12-31 $2,236,725 3,791,061
2025-09-30 $2,567,808 2,951,505
2025-06-30 $2,467,759 2,973,205
2022-09-30 $9,135 11,007
2022-06-30 $12,133 11,132
2022-03-31 $18,008 14,407
2021-09-30 $97,300 29,847
2021-06-30 $84,542 13,377